Daiichi Sankyo's leadership comments on DESTINY-Breast06 at #ASCO24
- blonca9
- Jun 2, 2024
- 1 min read
Global Head of Oncology Ken Keller and Chief Operating Officer Hiroyuki Okuzawa describe the significance of today's data and also comment on Daiichi's wider ADC platform.